Connecticut 2019 Regular Session

Connecticut Senate Bill SB01057

Introduced
3/12/19  
Introduced
3/12/19  
Refer
3/12/19  
Refer
3/12/19  
Report Pass
3/29/19  
Report Pass
3/29/19  
Refer
4/11/19  
Report Pass
4/17/19  

Caption

An Act Concerning Opioid Use Disorder.

Impact

The bill introduces mandates that state hospitals and emergency medical services report overdoses and administer mental health screenings as part of treatment protocols for opioid-related incidents. It also emphasizes mental health education alongside the distribution of opioid antagonists. Therefore, the bill enhances existing public health laws concerning substance use treatment and emergency medical care, presenting a multifaceted approach to dealing with drug addiction and its consequences. By ensuring greater access to treatment and immediate care resources, it aims to reduce mortality rates associated with opioid overdoses.

Summary

SB01057, known as An Act Concerning Opioid Use Disorder, addresses the growing crisis of opioid overdoses by instituting measures to improve the response of health institutions and communities to this public health issue. Among its significant provisions, the bill requires institutions of higher education to develop policies for the availability and use of opioid antagonists like naloxone, which can reverse opioid overdoses, ensuring that these lifesaving medications are accessible on campuses. This initiative is part of a broader strategy to combat the opioid crisis by increasing preparedness and responsiveness among young adults, who are vulnerable to drug abuse and overdose.

Sentiment

The sentiment surrounding SB01057 is largely positive, with strong support from health professionals, educators, and advocates for substance use reform who view it as a crucial step towards addressing the opioid epidemic. However, there is some contention regarding the funding and implementation of these policies, particularly in how institutions will manage the logistics of providing naloxone and the necessary training for personnel. Critics may express concerns over the effectiveness of such measures in isolation, emphasizing the need for comprehensive support systems that include longer-term addiction treatment and mental health support.

Contention

Among notable points of contention, the bill faces discussions regarding its practical implications for campuses, notably concerning the storage and access to opioid antagonists, as well as the training required for staff and students. While supportive voices laud the proactive approach to prevent overdoses, skeptics question the feasibility of full compliance within the existing frameworks of educational institutions, which may require additional resources and training. The successful enactment of SB01057 hence depends on careful consideration of these operational challenges.

Companion Bills

No companion bills found.

Similar Bills

CT HB07159

An Act Addressing Opioid Use.

CT SB01005

An Act Concerning The Department Of Public Health's Recommendations Regarding Revisions To Emergency Medical Services Definitions, Certification And Continuing Education Requirements.

CT HB06768

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Prescription Drug Regulation.

VA SB1035

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

FL H0783

Opioid Abatement

CT SB01058

An Act Concerning The Licensure Of Tattoo Technicians.

VA SB790

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

VA HB1637

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.